Evidence map›Paper›PMID 39137317›Full record

ArticleAmerican journal of respiratory and critical care medicine2024

Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study.

Margaret L Salisbury, Cheryl Markin, Tisra Fadely, Adam R Guttentag, Stephen M Humphries, David A Lynch, Jonathan A Kropski, Timothy S Blackwell

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Progressive pulmonary fibrosis.European radiology · 2026
    Review
  3. Review
  4. Mechanobiology and Resolution of Lung Fibrosis.Annual review of physiology · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Genetic Familial Interstitial Lung Disease.Clinics in chest medicine · 2025
    Review
  11. Article
  12. Pulmonary Fibrosis-Focusing on the Future: Aspen Lung Conference 2024 Summary.American journal of respiratory cell and molecular biology · 2025
    Article
  13. Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene.American journal of respiratory and critical care medicine · 2025
    Article
  14. Article
  15. Article
  16. Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease.American journal of respiratory and critical care medicine · 2024
    Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Margaret L SalisburyDepartment of Medicine and.ORCID 0000-0001-8217-6955
Cheryl MarkinDepartment of Medicine and.
Tisra FadelyDepartment of Medicine and.
Adam R GuttentagDepartment of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Stephen M HumphriesDepartment of Radiology, National Jewish Health, Denver, Colorado.ORCID 0000-0002-5113-4530
David A LynchDepartment of Radiology, National Jewish Health, Denver, Colorado.
Jonathan A KropskiDepartment of Medicine and.ORCID 0000-0002-8923-1344
Timothy S BlackwellDepartment of Medicine and.ORCID 0000-0002-0337-7052

Funding

Mechanisms of Familial Pulmonary FibrosisP01HL092870 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLACKWELL, TIMOTHY S. · 2010 to 2020
$21.6M
Project 4: Defining the Molecular Natural History of Early and Progressive Pulmonary FibrosisP01HL172729 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Timothy S. Blackwell · 2024 to 2026
$11.2M
Host Response, Lung Microbiome, and Clinical Phenotype in Hypersensitivity PneumoniaK23HL141539 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SALISBURY, MARGARET LOUISE · 2019 to 2023
$856k
Defining the biologic and physiologic trajectory of presymptomatic through advanced pulmonary fibrosisR56HL166941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SALISBURY, MARGARET LOUISE · 2023 to 2023
$768k
BLRD VA I01 BX002378Boehringer IngelheimNHLBI NIH HHS K23 HL141539NHLBI NIH HHS K23HL141539NHLBI NIH HHS P01 HL092870NHLBI NIH HHS P01HL092870NHLBI NIH HHS P01 HL172729NHLBI NIH HHS R56 HL166941
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ProgressionLung Diseases, InterstitialTomography, X-Ray ComputedAdultAgedCohort StudiesFemaleHumansIdiopathic Pulmonary FibrosisLungMaleMiddle AgedProspective StudiesRisk Factorsinterstitial lung diseasepulmonary fibrosissecondary disease prevention

Identifiers

PMID39137317
PMCPMC11716039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.